Kornelia Kotseva, MD, PhD, Cardiovascular Medicine, National Heart and Lung Institute, Imperial College School of Science, Technology and Medicine, London; and David Wood, Professor, Cardiovascular Medicine, National Heart and Lung Institute, Imperial College School of Science, Technology and Medicine, London.
Kornelia Kotseva, Thomas Peason.
Kornelia Kotseva of Imperial College London, London (Imperial) Read .
Kornelia Kotseva of Imperial College London, London (Imperial) Read 219 publications Contact Kornelia Kotseva. Objective: The objective of this study was to determine time trends in the implementation of European guidelines on the management of cardiovascular disease prevention in people at high cardiovascular risk. Opinion statement: Passive dissemination of guidelines in isolation is generally ineffective and results in only small changes in practice.
Kornelia Kotseva, David А. Wood, +2. .Publications referenced by this paper. Showing 1-10 of 36 references. Sort by. Influence Recency. Wood, +2 authors for the Euroaspire Study Group. Published in The Lancet 2009. 1016/S0140-6736(09)60330-5. Cardiovascular prevention in coronary heart disease patients: guidelines implementation in clinical practice. The Log book for the secondary prevention of coronary artery disease: A pilot study. Aurélien Vaillant, Gilles Dentan, +10 authors Gilles Morel.
Most cardiovascular diseases can be prevented by addressing behavioural risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol using population-wide strategies. People with cardiovascular disease or who are at high cardiovascular risk (due to the presence of one or more risk factors such as hypertension, diabetes, hyperlipidaemia or already established disease) need early detection and management using counselling and medicines, as appropriate. What are cardiovascular diseases?
Global Cardiovascular Disease Prevention – A Call to Action for Nursing A.
Global Cardiovascular Disease Prevention – A Call to Action for Nursing A Consensus Document from . In the fourth article in this series, Fletcher and colleagues present Community-Based and Public Health Prevention Initiatives and explain why they are necessary, and why, with support from policy makers, such initiatives can be highly successful in encouraging and enabling be-havior change for groups of people. Wood DA, Kotseva K. Should cardiovascular disease prevention be undertaken by doctors or policymakers and politicians? Dialogues Cardiovasc Med 2009;14(2):83–98. Morel CM, Acharya T, Broun D, et al.
Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. EUROASPIRE III: a survey on the lifestyle . Global cardiovascular disease prevention: a call to action for nursing: the global burden of cardiovascular disease.
Eur J Cardiovasc Prev Rehabil.
This book is based on the European Guidelines on CVD Prevention (formulated by eight societies). It covers prevention strategies, risk factors, detection, management of risk, and therapeutic targets. It gives the rationale for the prevention of CVD along with practical clinical strategies across the spectrum of clinical care. The starting point is patients with symptomatic atherosclerotic disease, such as coronary artery disease, stroke and peripheral arterial disease. The next patient group is those who are apparently healthy, but at high risk of developing CVD.
Our team is growing all the time, so we’re always on the lookout for smart people who want to help us reshape the world of scientific publishing.